• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 977

D-tagatose produced via novel enzymatic cascade

Intended Use: Intended for use as a nutritive sweetener, flavor enhancer, humectant, texturizer, and stabilizer at levels ranging from 1 to 100% in multiple food categories.
Basis: Scientific procedures
Notifier: Bonumose, LLC
Notifier Address: 1725 Discovery Drive, Suite 220
Charlottesville, VA 22911
GRAS Notice (releasable information): GRN 977 with amendment (in PDF) (4.0 MB)
Date of closure: Oct 21, 2021
FDA's Letter: FDA has no questions (in PDF) (153 kB)